• Health
  • Science
  • U.S.
  • Technology
  • Business
  • World
  • Politics
  • Entertainment
  • Sports

Building a Better World

News and information

  • Home
  • Privacy Policy
  • Contact Us
  • Our Team

Controversial drug may help prevent painful amputations

May 7, 2016 By Sam Catherman

Controversial drug may help prevent painful amputations

Scientists say this drug could help a wide range of people avoid amputations and even death.

Though they have been the source of much controversy from scientists weighing the relative risks and benefits, statins remain a mainstay in the pharmaceutical world. Primarily used to treat cholesterol, the drugs have a list of side effects that have caused concern in a number of researchers.

But according to U.S. News and World Report, a recent study suggests that taking the drugs could help eliminate the need for amputation and the possibility of death in people with narrow leg arteries, a condition known as peripheral artery disease, or PAD.

According to the study’s author, Dr. Shipra Arya from the division of vascular surgery at Emory University School of Medicine in Atlanta, “PAD a narrowing of the peripheral arteries to the legs, stomach, arms and head, is the next cardiovascular epidemic.”

Dr. Arya and her research team examined health information collected from over 200,000 veterans suffering from peripheral artery disease. Scientists singled out the patients who had begun taking statins near the time when they were diagnosed with PAD, and recorded the dosage of the drugs each veteran was taking.

During the study’s follow-up period, which checked in with patients an average of 5.2 years after it began, researchers divided the veterans into three groups. One group represented vets who were taking high statin doses, one group had veterans who took medium to low doses, of the drug, and the last group had vets that didn’t take any statins.

Scientists found that vets taking statins while suffering from PAD had a 33 percent lower risk of having a limb amputated, and a 29 percent lower chance of death than those who didn’t take these drugs. Patients taking a moderate to low dose were 22 percent less likely than the control group to experience amputation or death.

“Patients who have been diagnosed with PAD should be considered for placement on high-dose statins upon diagnosis is they can tolerate it, along with other medical management, including smoking cessation, anti-platelet therapy and a walking program,” said Arya.

A press release from the American Heart Association describing the details of the study can be found here.

 

Sharing

Facebooktwittergoogle_plusredditpinterestlinkedintumblrmail

Filed Under: Front Page, Health

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Follow Us

Facebookrss

Search:

Recent Posts

  • NASA’s InSight spacecraft makes important course correction May 26, 2018
  • Scientists outraged at latest Trump decision May 15, 2018
  • Huge uproar erupts over major incident at Utah park May 13, 2018
  • Incredible moon discovery stuns scientists May 12, 2018
  • Authorities shocked by discovery about common painkiller May 6, 2018
  • Outrageous crocodile experiment stuns scientists May 5, 2018
  • Great Barrier Reef is too quiet, scientists say May 1, 2018
  • Massive Hiroshima bomb discovery shocks scientists May 1, 2018
  • Earth will be slammed by massive asteroid April 29, 2018
  • Teens are doing something incredibly alarming in schools April 29, 2018
  • Huge discovery in Tasmania stuns scientists April 28, 2018
  • Shocking discovery in New Jersey stuns authorities April 22, 2018
  • Huge volcanic explosion could wipe out the United States April 21, 2018
  • Huge controversy erupts over world’s hottest pepper April 15, 2018
  • SpaceX is about to do something astonishing April 15, 2018

Copyright © 2021 Jones Kilmartin Group, LLC · Metro Pro Theme On Genesis Framework · WordPress